======= SMYD3 ======= == Gene Information == * **Official Symbol**: SMYD3 * **Official Name**: SET and MYND domain containing 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64754|64754]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H7B4|Q9H7B4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SMYD3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SMYD3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608783|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Histone methyltransferase. Specifically methylates 'Lys- 4' of histone H3, inducing di- and tri-methylation, but not monomethylation (PubMed:15235609, PubMed:22419068). Also methylates 'Lys-5' of histone H4 (PubMed:22419068). Plays an important role in transcriptional activation as a member of an RNA polymerase complex (PubMed:15235609). Binds DNA containing 5'- CCCTCC-3' or 5'-GAGGGG-3' sequences (PubMed:15235609). {ECO:0000269|PubMed:15235609, ECO:0000269|PubMed:22419068}. |SET| |zf-MYND| |RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding| |histone-lysine N-methyltransferase activity| |myotube cell development| |cellular response to dexamethasone stimulus| |RNA polymerase II complex binding| |response to dexamethasone| |cellular response to glucocorticoid stimulus| |myotube differentiation| |cellular response to corticosteroid stimulus| |histone lysine methylation| |peptidyl-lysine methylation| |cellular response to ketone| |histone methylation| |response to antineoplastic agent| |positive regulation of peptidyl-serine phosphorylation| |nucleosome assembly| |protein alkylation| |protein methylation| |chromatin assembly| |striated muscle cell development| |regulation of peptidyl-serine phosphorylation| |response to glucocorticoid| |muscle cell development| |chromatin assembly or disassembly| |nucleosome organization| |response to corticosteroid| |DNA packaging| |cellular response to xenobiotic stimulus| |cellular response to steroid hormone stimulus| |response to ketone| |striated muscle cell differentiation| |protein-DNA complex assembly| |negative regulation of protein kinase activity| |protein-DNA complex subunit organization| |muscle cell differentiation| |negative regulation of kinase activity| |macromolecule methylation| |negative regulation of transferase activity| |DNA conformation change| |response to xenobiotic stimulus| |methylation| |peptidyl-lysine modification| |response to steroid hormone| |histone modification| |covalent chromatin modification| |cellular response to drug| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |muscle structure development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |cellular response to organic cyclic compound| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |cellular response to hormone stimulus| |chromatin organization| |negative regulation of catalytic activity| |regulation of protein kinase activity| |cellular protein-containing complex assembly| |response to lipid| |regulation of kinase activity| |peptidyl-amino acid modification| |response to hormone| |response to organic cyclic compound| |regulation of transferase activity| |positive regulation of protein phosphorylation| |response to drug| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |chromosome organization| |negative regulation of protein metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of molecular function| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |regulation of protein phosphorylation| |response to endogenous stimulus| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |protein-containing complex assembly| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp134|MS023 2μM R03 exp134]]|1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6751 * **Expression level (log2 read counts)**: 3.95 {{:chemogenomics:nalm6 dist.png?nolink |}}